Although contrast agents have an essential role in non-invasive imaging techniques, potential side effects limit their use. For example, both low- and iso-osmolar iodinated contrast media used in ...
Cardiovascular medicine is changing. It is progressively becoming more and more disease-based for diagnosis and therapy with the development of multidisciplinary meetings, often image guided. Some of ...
A cardiologist has just called upon the US Food and Drug Administration to reconsider a strong warning it recently placed on a diagnostic tool, stating that the warning could prevent doctors from ...
BOSTON--(BUSINESS WIRE)--A comprehensive new study based on nationwide claims data from more than 11 million patients shows that diagnostic contrast-enhanced ultrasound (CEUS) exams are safe and can ...
Transthoracic echocardiography utilizes both visual (qualitative) and quantitative tools to evaluate cardiac structure and function Traditional techniques, such as two-dimensional and Doppler imaging, ...
Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...
The Food and Drug Administration (FDA) has approved Lumason (sulfur hexafluoride lipid-type A microspheres; Bracco Diagnostics Inc.), an ultrasound enhancing agent, for use in echocardiography to ...
N. BILLERICA, Mass.--(BUSINESS WIRE)-- Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced that the U.S. Food and Drug Administration (FDA) has accepted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results